Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ENPP1 inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | - | 30 Dec 2025 | |
Metastatic Solid Tumor | Phase 1 | - | 30 Dec 2025 | |
Solid tumor | IND Approval | US | 21 Nov 2024 |
Not Applicable | - | vaazzyehgu(foojfdiiid) = hpnvvgivxk getyffjeqf (ixsayyyiwm ) | Positive | 02 Nov 2023 | |||
ISM5939 + anti-PD-L1 therapy | vaazzyehgu(foojfdiiid) = ginlkndmyy getyffjeqf (ixsayyyiwm ) |